Fri, March 22, 2024
Thu, March 21, 2024
Wed, March 20, 2024
Tue, March 19, 2024
Mon, March 18, 2024

Raghuram Selvaraju Reiterated (AXSM) at Strong Buy and Held Target at $180 on, Mar 20th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-180-on-mar-20th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $180 on, Mar 20th, 2024.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Raghuram


  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $108 on, Tuesday, March 19th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, February 27th, 2024
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $103 on, Wednesday, February 21st, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Decreased Target to $123 on, Wednesday, February 21st, 2024
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $125 on, Wednesday, February 21st, 2024
  • Ashwani Verma of "UBS" Initiated at Strong Buy and Held Target at $111 on, Tuesday, February 6th, 2024
  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $113 on, Tuesday, January 16th, 2024
  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $125 on, Wednesday, December 13th, 2023

Publication Contributing Sources